SNRPC and U1 SnRNP: A Key Interaction in Cellular Regulation (G6631)

Target Name: SNRPC

NCBI ID: G6631

SNRPC

SNRPC and U1 SnRNP: A Key Interaction in Cellular Regulation

SNRPC (short for SnRNA-protein complex), is a protein that is expressed in various tissues and cells of the body. It is a key player in the regulation of gene expression and has been implicated in a number of cellular processes, including cell growth , differentiation, and stress responses.

One of the unique features of SNRPC is its ability to interact with specific proteins, known as U1 snRNP chaperone, to regulate their stability and function. This interaction between SNRPC and U1 snRNP has been the focus of much research in recent years, as it is believed to play a crucial role in the regulation of gene expression and the development of various diseases.

The U1 snRNP is a small RNA molecule that plays a critical role in the regulation of gene expression by binding to specific protein-coding RNAs. It is composed of two subunits, U1 and U2, which are held together by a conserved ion-pair. U1 snRNP has been shown to interact with a wide variety of proteins, including those that are involved in cell signaling pathways, DNA replication, and stress responses.

SNRPC is another protein that has been shown to interact with U1 snRNP. It is a 14-kDa protein that is composed of a N-terminal alpha-helicase domain, a middle catalytic domain, and a C-terminal T-loop domain. The T-loop domain is thought to play a key role in the interaction between SNRPC and U1 snRNP, as it is able to form a stable complex with the U1 snRNP subunit.

The interaction between SNRPC and U1 snRNP has been shown to play a critical role in the regulation of gene expression and the development of various diseases. For example, studies have shown that SNRPC can modulate the stability and activity of U1 snRNP, leading to changes in gene expression and cellular behavior. This interaction between SNRPC and U1 snRNP is also thought to be involved in the regulation of stress responses, as it has been shown to play a role in the regulation of cellular stress responses, including the stress-induced apoptosis that occurs in response to oxidative stress.

In addition to its role in the regulation of gene expression, SNRPC is also a potential drug target and biomarker. The interaction between SNRPC and U1 snRNP is thought to be a useful target for the development of drugs that can modulate the activity of SNRPC and U1 snRNP. This is an area of 鈥嬧?媜ngoing research, and a number of potential drugs that are currently in development are aimed at modulating the interaction between SNRPC and U1 snRNP.

Overall, SNRPC is a protein that is involved in a number of cellular processes and has been implicated in the regulation of gene expression and the development of various diseases. The interaction between SNRPC and U1 snRNP is a key aspect of this regulation and is the focus of much research in this field. While the full implications of this interaction are still being explored, it is clear that it has the potential to be a valuable drug target and biomarker in the future.

Protein Name: Small Nuclear Ribonucleoprotein Polypeptide C

Functions: Component of the spliceosomal U1 snRNP, which is essential for recognition of the pre-mRNA 5' splice-site and the subsequent assembly of the spliceosome. SNRPC/U1-C is directly involved in initial 5' splice-site recognition for both constitutive and regulated alternative splicing. The interaction with the 5' splice-site seems to precede base-pairing between the pre-mRNA and the U1 snRNA. Stimulates commitment or early (E) complex formation by stabilizing the base pairing of the 5' end of the U1 snRNA and the 5' splice-site region

The "SNRPC Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about SNRPC comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets